To discover anticancer drugs with novel structures and expand our research scope, pyrazoline derivatives (-) were designed and synthesized through cyclization of chalcones with thiosemicarbazide/semicarbazide in CHCOOH as a solvent. All newly synthesized pyrazoline derivatives were fully characterized using several spectroscopic experiments such as H, C NMR, FT-IR spectroscopy, and mass analysis. By , the purity of all analogs was found above and both lead compounds ( and ) were also validated by . Anticancer activity of synthesized pyrazoline derivatives (-) was investigated by the MTT assay against the human lung cancer cell (A549), human cervical cancer cell (HeLa), and human primary normal lung cells (HFL-1). Staurosporine (STS) was used as a standard drug. The anticancer results showed that two potent analogs and exhibit excellent activity against (IC = 13.49 ± 0.17 and 22.54 ± 0.25 μM) and cells (IC = 17.52 ± 0.09 and 24.14 ± 0.86 μM) and low toxicity against the HFL-1 (IC = 114.50 ± 0.01 and 173.20 ± 10 μM). The flow cytometry was further used to confirm the anticancer activity of potent derivatives against the A549 cancer cell line. DNA binding interaction of anticancer agents and with Ct-DNA has been carried out by absorption, fluorescence, EtBr (dye displacement assay), circular dichroism, cyclic voltammetry and time-resolved fluorescence, which showed noncovalent binding mode of interaction. Anticancer activity of both lead compounds ( and ) may be attributed to DNA binding. The evaluation of the antioxidant potential of pyrazoline analogs 3a and 3h by 2,2-diphenyl-1-picrylhydrazyl free radical showed promising antioxidant activity with IC values of 0.132 ± 0.012 and 0.215 ± 0.025 μg/mL, respectively. In silico molecular docking of pyrazoline derivatives was also performed using autodock vina software against the DNA hexamer with PDB ID: 1Z3F and ADMET properties to explore their best hits.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260921 | PMC |
http://dx.doi.org/10.1021/acsomega.2c02033 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!